2025 annual financial data
Adial Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -7,799,462 USD and net income was -7,977,171 USD.
Operating cash flow was -6,492,603 USD.
Get free Adial Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,799,462 USD
- Net income
- -7,977,171 USD
- Operating cash flow
- -6,492,603 USD